Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1996
06/19/1996CN1124978A Cell matrix stimulated cell attachment and hemidesmosome assembly
06/19/1996CN1124928A Antibodies to P-selectin and their uses
06/18/1996US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies
06/18/1996US5527885 Useful for delivering drugs or radioisotopes to target organs, tumors or thrombi in vivo
06/18/1996US5527805 Dna-cleaving, cytotoxic and anti-tumor compounds
06/18/1996US5527770 Immunotherapeutic agent derived from bacteria
06/18/1996US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics
06/18/1996US5527700 Target antigens of transmission blocking antibodies for malaria parasites
06/18/1996US5527529 Vaccines comprising attenuated salmonella having mutations in the ompr genes
06/18/1996CA2071954C Matrix with adherently bound cells and process for producing viruses/virus antigens
06/13/1996WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms
06/13/1996WO1996017938A1 Glycoproteins from herpes virus and vaccines containing them
06/13/1996WO1996017936A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
06/13/1996WO1996017931A1 Human vascular ibp-like growth factor
06/13/1996WO1996017874A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017863A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996WO1996017614A1 Adjuvant-incorporated cellular antigens: conjugation and methods
06/13/1996WO1995034670A3 Recombinant aav genome encoding immunodeficiency virus protein
06/13/1996DE19512346C1 Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin A process for the purification of pertussis toxin and Filamenthämagglutinin
06/13/1996CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
06/13/1996CA2206471A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996CA2204738A1 Induction of cytotoxic t-lymphocyte responses
06/12/1996EP0716095A1 Method for quantitative determination of fas antigen
06/12/1996EP0716094A1 Process for purifying hepatitis B viral surface antigen comprising preS2 peptide
06/12/1996EP0715653A1 Humanised antibodies
06/12/1996EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy
06/12/1996EP0463151B1 Generation of xenogeneic antibodies
06/12/1996EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity
06/12/1996EP0373192B1 Diagnostic genes for toxoplasmosis
06/12/1996CN1124502A Mammal cell lines and method of obtaining glycoproteins
06/12/1996CN1124501A Anti-EGFR single-chain Fvs and anti-EGFR antibodies
06/12/1996CN1124491A Inhibitor of stem cell proliferation and uses thereof
06/12/1996CN1124456A Gonococcal anti-idiotypic antibodies and methods and compositions using them
06/12/1996CN1124163A Epidemic encephalitis B vaccine and preparation by using Lepidoptera Mybhimua separata ovary cells
06/12/1996CN1032019C Process for recombinant biocides using organisms
06/11/1996US5525715 Codes specific polypeptide; useful vaccine to immunize human infected from polio virus
06/11/1996US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells
06/11/1996US5525519 Precipitating with a ph adjusted solution of polyoxyethylene glycol and polyvinylpyrrolidone
06/11/1996US5525510 Injector for accelerating carrier particles, with coatings containing genetic material, in high speed gas stream which separates from particles just before they impact living tissues
06/11/1996US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column
06/11/1996US5525502 DNA encoding chitin deacetylase
06/11/1996US5525489 Antipertussis vaccines
06/11/1996US5525487 DNA encoding I-CAM related protein
06/11/1996US5525486 Genetic engineering
06/11/1996US5525474 Immunoassay; linking the haptenic drug via its maleimide moiety and a sulfhydryl bridge to an immunogenic carrier to stimulate antibodies
06/11/1996US5525342 Reovirus strain 2177 and vaccine containing same
06/11/1996US5525338 Detection and therapy of lesions with biotin/avidin conjugates
06/11/1996US5525337 Detecting tumor cells by removing tissue or fluid sample, reacting with antibody capable of binding to surface antigen, detecting presence of antibody-antigen complex
06/11/1996CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
06/11/1996CA1338381C Minactivin - (plasminogen activator inhibitor-2)
06/11/1996CA1338380C Shuttle vector
06/10/1996CA2158116A1 Method for inducing superovulation in cattle
06/09/1996CA2164374A1 Method for quantitative determination of fas antigen
06/06/1996WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination
06/06/1996WO1996017065A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
06/06/1996WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
06/06/1996WO1996017053A1 Vectors for tissue-specific replication
06/06/1996WO1996016990A1 Humanized antibodies to cd38
06/06/1996WO1996016988A1 Reagents and processes for targeting mutant epidermal growth factor receptors
06/06/1996WO1996016673A1 Method of promoting an immune response with a bispecific antibody
06/06/1996WO1996016672A1 Serially passaged african green monkey kidney cells
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/06/1996CA2207869A1 Method of promoting an immune response with a bispecific antibody
06/06/1996CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
06/06/1996CA2204920A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids for coding for the same and use thereof in diagnostic and prophylactic methods and kits
06/06/1996CA2201585A1 Serially passaged african green monkey kidney cells
06/05/1996EP0714988A2 Method for quantifying nucleic acids
06/05/1996EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands
06/05/1996EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors
06/05/1996EP0714665A2 Osteogenic devices
06/05/1996EP0714662A1 Antiallergic agent
06/05/1996EP0714513A1 Molecular clones producing recombinant dna antigens of the hards virus
06/05/1996EP0714511A1 Methods of detecting and combating disorders of the central nervous system
06/05/1996EP0714510A1 Natural killer cell-specific antigen and antibodies that identify the same
06/05/1996EP0714444A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
06/05/1996EP0714443A1 Detection and prevention of mycoplasma hominis infection
06/05/1996EP0714442A1 Recombinant alternaria alternata allergenes
06/05/1996EP0714441A1 Recombinant cladosporium herbarum allergens
06/05/1996EP0714440A1 T cell epitopes of ryegrass pollen allergen
06/05/1996EP0714439A1 Recombinant humanized anti-human immunodeficiency virus antibody
06/05/1996EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
06/05/1996EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
06/05/1996EP0714409A1 Antibodies
06/05/1996EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
06/05/1996EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
06/05/1996EP0714307A1 Vaccine compositions
06/05/1996EP0714306A1 Inactivated respiratory syncytial viral vaccines
06/05/1996EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
06/05/1996EP0497825B1 Anti-viral material
06/05/1996EP0465560B1 VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS
06/05/1996EP0312542B1 Gamma, delta t cell receptor and methods for detection
06/05/1996CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy
06/05/1996CN1124013A Influenza vaccine compositions containing 3-O-deacylated monophosphoryl lipid a
06/04/1996US5523490 Antitumor agents
06/04/1996US5523089 Borrelia antigen
06/04/1996US5523085 Monoclonal antibody in destruction of small cell lung carcinoma
05/1996
05/30/1996WO1996016184A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems
05/30/1996WO1996016178A1 Immunogens for stimulating mucosal immunity
05/30/1996WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
1 ... 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 ... 1823